Feed excerpt — reported by STAT News
As 'three-parent IVF' expands globally, scientists and ethicists are rethinking use of mitochondrial replacement technology to reduce risk of inherited rare diseases.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →